The device was not returned for analysis.
A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.
Additionally, a review of the complaint history identified no other complaints from the lot.
All information was investigated, and the difficult positioning associated with difficulty crossing the septum with the steerable guide catheter (sgc) appears to be related to the suboptimal transseptal puncture and therefore, related to patient conditions.
However, a cause for the reported sgc leak cannot be determined.
The reported air embolism resulting in hypotension appears to be related to the procedural conditions associated with the sgc leak.
Air embolism and hypotension are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.
The unexpected medical intervention was a result of case-specific circumstances.
There is no indication of a product issue with respect to manufacture, design or labeling.
|
This is filed to report leak, air embolism and medical intervention.
It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4.
It was noted suboptimal transseptal puncture.
The steerable guide catheter (sgc) crossed the septum; however, crossing the septum was difficult due to the suboptimal transseptal puncture and air was observed in the left atrium.
Additionally, the patient's blood pressure dropped.
Therefore, the 3-way stopcock was opened and closed.
No new air was observed.
Medication was administered to treat the blood pressure drop and stabilize the patient.
The procedure continued, and a clip delivery system (cds) was advanced through the sgc.
However, due to an aorta hugger, the cds was difficult to orient above the leaflets.
Troubleshooting was unsuccessful, therefore a decision was made to make another transseptal puncture.
The septum was punctured 2 cm above the fossa ovalis and the procedure continued.
The cds was advanced to the mitral valve, and the clip was deployed.
One clip was implanted, reducing mr to 1.
There was no clinically significant delay in the procedure.
No additional information was provided.
|